{"title":"Impact of nutrient deficiency and harvesting strategy on biomass and phycocyanin production in <i>Spirulina</i> cultures.","authors":"Hooi Ren Lim, Kuan Shiong Khoo, Pau Loke Show","doi":"10.3389/fbioe.2025.1546801","DOIUrl":null,"url":null,"abstract":"<p><p>Recent research has focused on issues related to contamination, nutrient availability, and strain selection, but there has been insufficient focus on harvesting research. This study employed an integrated continuous cultivation and harvesting strategy for a <i>Spirulina</i> microalgae biorefinery. The effects of nutrient-deficiency, harvesting ratio, and NaNO<sub>3</sub> addition on biomass concentration and productivity and phycocyanin accumulation of <i>Spirulina</i> were investigated. The lowest biomass productivity of 0.015 g/L/day was observed in <i>Spirulina</i> cultivated in NaNO<sub>3</sub> deficient medium. A harvesting ratio of 10% showed a consistent range of harvested dry biomass weight (0.20-0.22 g). Addition of 2.50 g/L NaNO<sub>3</sub> resulted in a significant increase in C-phycocyanin (C-PC) and allophycocyanin (APC) concentration from 34.37 mg/g to 68.35 and 27.08 to 33.23 mg/g, respectively. Biomass productivity of 1-L and 10-L batch culture was found to be 0.23 g/L/d and 0.21 g/L/d, respectively. Both 1-L and 10-L batch cultures showed a significant increase in phycocyanin accumulation due to the addition of 2.50 g/L of NaNO<sub>3</sub>. These findings highlight the feasibility of continuous cultivation and optimized harvesting for scalable biomass and phycocyanin production, offering valuable insights for industrial biorefineries that seek to enhance microalgae-based bioactive compound extraction.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1546801"},"PeriodicalIF":4.3000,"publicationDate":"2025-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11973517/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1546801","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Recent research has focused on issues related to contamination, nutrient availability, and strain selection, but there has been insufficient focus on harvesting research. This study employed an integrated continuous cultivation and harvesting strategy for a Spirulina microalgae biorefinery. The effects of nutrient-deficiency, harvesting ratio, and NaNO3 addition on biomass concentration and productivity and phycocyanin accumulation of Spirulina were investigated. The lowest biomass productivity of 0.015 g/L/day was observed in Spirulina cultivated in NaNO3 deficient medium. A harvesting ratio of 10% showed a consistent range of harvested dry biomass weight (0.20-0.22 g). Addition of 2.50 g/L NaNO3 resulted in a significant increase in C-phycocyanin (C-PC) and allophycocyanin (APC) concentration from 34.37 mg/g to 68.35 and 27.08 to 33.23 mg/g, respectively. Biomass productivity of 1-L and 10-L batch culture was found to be 0.23 g/L/d and 0.21 g/L/d, respectively. Both 1-L and 10-L batch cultures showed a significant increase in phycocyanin accumulation due to the addition of 2.50 g/L of NaNO3. These findings highlight the feasibility of continuous cultivation and optimized harvesting for scalable biomass and phycocyanin production, offering valuable insights for industrial biorefineries that seek to enhance microalgae-based bioactive compound extraction.
期刊介绍：
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
